ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,261Medicare Part D Prescriptions Filled, Including Refills

Rank: 312 out of 5176

$794K Total Retail Price of All Prescriptions

Rank: 461 out of 5176

328 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 328 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 328 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 11,770 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 580 557 1 13
FUROSEMIDE 520 516 2 8
LEVOTHYROXINE SODIUM 414 382 3 4
METOPROLOL TARTRATE 385 372 4 6
SIMVASTATIN 365 335 5 1
AMLODIPINE BESYLATE 337 301 6 2
LISINOPRIL 315 293 7 5
CITALOPRAM HBR 304 273 8 31
DONEPEZIL HCL 283 272 9 28
NAMENDA 261 242 10 47
LANTUS 220 183 11 66
GABAPENTIN 214 197 12 21
TAMSULOSIN HCL 195 166 13 20
RISPERIDONE 172 119 14 78
ATENOLOL 165 165 15 12
MIRTAZAPINE 158 154 16 45
PREDNISONE 153 134 17 52
CARVEDILOL 147 145 18 24
SERTRALINE HCL 147 142 18 30
FAMOTIDINE 143 125 20 58
KLOR-CON M20 141 139 21 129
LEVETIRACETAM 136 100 22 92
IPRATROPIUM-ALBUTEROL 134 129 23 138
POTASSIUM CHLORIDE 121 121 24 34
NOVOLOG 115 88 25 168
DIOVAN 112 109 26 19
OXYCODONE-ACETAMINOPHEN 108 90 S2 27 101
SANTYL 108 107 27 124
NOVOLIN R 106 97 29 191
ISOSORBIDE MONONITRATE ER 105 94 30 44
OMEPRAZOLE 100 99 31 3
NYSTATIN-TRIAMCINOLONE 95 92 32 142
METOPROLOL SUCCINATE 94 83 33 11
LEVOFLOXACIN 92 84 34 109
DIVALPROEX SODIUM 88 75 35 104
SULFAMETHOXAZOLE-TRIMETHOPRIM 88 82 35 181
QUETIAPINE FUMARATE 88 88 35 75
GLIMEPIRIDE 87 87 38 37
ESCITALOPRAM OXALATE 84 47 39 89
NYSTATIN 84 70 39 168
CLOPIDOGREL 84 77 39 26
TRAVATAN Z 80 64 42 234
PAROXETINE HCL 79 57 43 93
LATANOPROST 77 77 44 185
HYDROCHLOROTHIAZIDE 75 75 45 10
ABILIFY 75 57 45 273
CARBIDOPA-LEVODOPA 74 74 47 98
TRAZODONE HCL 74 72 47 71
FINASTERIDE 71 66 49 69
BACLOFEN 71 56 49 173
AZITHROMYCIN 69 66 51 42
ADVAIR DISKUS 69 64 51 32
OLANZAPINE 69 60 51 140
VENLAFAXINE HCL ER 68 43 54 186
LEVEMIR 68 58 54 252
ATORVASTATIN CALCIUM 67 61 56 9
LAMOTRIGINE 65 21 57 289
DIGOXIN 64 64 58 56
CIPROFLOXACIN HCL 64 57 58 84
AMOX TR-POTASSIUM CLAVULANATE 61 61 60 141
FENTANYL 61 55 S2 60 172
POLYETHYLENE GLYCOL 3350 60 56 62 74
NATEGLINIDE 59 59 63 272
CLONIDINE HCL 59 47 63 79
PROMETHAZINE HCL 58 18 R 65 221
SPIRONOLACTONE 58 58 65 88
HALOPERIDOL 57 43 67 145
ALLOPURINOL 57 57 67 41
BUSPIRONE HCL 57 45 67 183
PLAVIX 56 51 70 29
CYMBALTA 54 54 71 90
TRAMADOL HCL 53 46 72 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.